We hypothesised that different isoforms of IL33, that may be more prevalent in the airways of patients with asthma, may differentially activate IL1RL1 and that asthma‐associated IL1RL1 nonsynonymous variation may further modify the magnitude of this signalling response. The gene discussed is IL33; the disease is asthma.